Cardiff Oncology (CRDF) Retained Earnings (2011 - 2026)

Cardiff Oncology has reported Retained Earnings for 15 years, with the latest figure at $50000.0 in Q4 2025.

• Quarterly Retained Earnings rose 100.01% year-over-year to $50000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $50000.0 (up 100.01% YoY) and the FY2025 annual result came in at $50000.0, up 100.01% from the prior year.
• Retained Earnings held at $50000.0 in Q4 2025 per CRDF's latest filing, from $50000.0 in the prior quarter.
• Over five years, Retained Earnings peaked at $468.5 million in Q1 2025 and troughed at -$384.2 million in Q4 2024.
• A 5-year average of $1.5 million and a median of -$202500.0 in 2021 frame the typical range for Retained Earnings.
• The widest YoY moves for Retained Earnings: up 261.3% in 2022, down 2812480.0% in 2022.
• Over 5 years, Retained Earnings stood at $400.5 million in 2021, then plunged by 100.1% to -$395000.0 in 2022, then tumbled by 85859.75% to -$339.5 million in 2023, then decreased by 13.15% to -$384.2 million in 2024, then jumped by 100.01% to $50000.0 in 2025.
• According to Business Quant data, Retained Earnings over the past three periods registered $50000.0, $50000.0, and $17000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.